Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Merck & Co Inc's (NYSE:MRK) Q4 sales reached $13.52 billion, +24% Y/Y, beating the consensus of $13.16 billion.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- Excluding the foreign exchange impact, revenues were up 23%.
- Pharmaceutical sales increased 23% to $12 billion, reflecting sales of molnupiravir and growth in oncology, vaccines, and hospital acute care products.
- COVID-19 treatment drug Molnupiravir sales were $952 million, primarily consisting of sales in the U.S., the U.K., and Japan.
- Related: Merck's COVID-19 Pill works Against Omicron, Lab Studies Show.
- Keytruda sales grew 15% to $4.6 billion. Vaccine sales rebounded, and Gardasil/ Gardasil 9 sales were up 53% to $1.5 billion, primarily driven by strong global demand, particularly in China.
- Vaccine performance was negatively affected by lower sales of PNEUMOVAX 23 pneumococcal vaccine, which declined 14% to $292 million on lower demand in the U.S., reflecting prioritization of COVID-19 vaccines.
- Adjusted EPS of $1.80 also surpassed the analysts' estimate of $1.53 and up from $0.98 posted a year ago.
- 2022 Guidance: Merck expects FY22 sales of $56.1 billion - $57.6 billion, compared to the consensus of $56.64 billion.
- It expects an adjusted EPS of $7.12 and $7.27 (consensus $7.29).
- Price Action: MRK shares are down 0.33% at $81.74 during the premarket session on the last check Thursday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.